Mszar, Reed
Katz, Miriam E.
Grandhi, Gowtham R.
Osei, Albert D.
Gallo, Antonio
Blaha, Michael J.
Article History
Accepted: 3 April 2024
First Online: 25 April 2024
Declarations
:
: Dr. Gallo has received grants and personal fees from Amgen, Sanofi and Regeneron, Mylan Viatris, MSD, Akcea Therapeutics, Amryt, Novartis, Servier, Eli Lilly, Ultragenyx. Dr. Blaha has received grants from NIH, FDA, AHA, Amgen, Novo Nordisk, Bayer and is on the Advisory Boards of Novartis, Novo Nordisk, Bayer, Roche, Merck, Astra Zeneca, Boehringer Inhgelheim, Agepha, Vectura.
: This article does not contain any studies with human or animal subjects performed by any of the authors.